T T T Huyen1, N V Nhung1, H D Shewade2, N B Hoa3, A D Harries4. 1. Viet Nam National Tuberculosis Control Programme/National Lung Hospital, Hanoi, Viet Nam. 2. International Union Against Tuberculosis and Lung Disease (The Union) South-East Asia Regional Office, New Delhi, India. 3. Viet Nam National Tuberculosis Control Programme/National Lung Hospital, Hanoi, Viet Nam ; The Union, Paris, France. 4. The Union, Paris, France ; London School of Hygiene & Tropical Medicine, London, UK.
Abstract
SETTING: The National Tuberculosis (TB) Programme in Viet Nam and Ho Chi Minh City (HCMC). OBJECTIVES: To determine 1) at national level between 2011 and 2013, the relationship between human immunodeficiency virus (HIV) testing, uptake of TB-HIV interventions and adverse treatment outcomes among TB-HIV patients; and 2) in HCMC in 2013, patient characteristics associated with adverse outcomes. DESIGN: An ecological study reviewing aggregate nationwide data and a retrospective cohort review in HCMC. RESULTS: Nationwide, from 2011 to 2013, HIV testing increased in TB patients from 58% to 68% and antiretroviral therapy (ART) increased in TB-HIV patients from 54% to 63%. Adverse treatment outcomes in TB-HIV patients increased from 24% to 27%, largely due to transfer out (5-9% increase) and death. The Northern and Highland regions showed poor uptake of TB-HIV interventions. In HCMC, 303 (27%) of 1110 TB-HIV patients had adverse outcomes, with higher risks observed in those with previously treated TB, those diagnosed as HIV-positive before TB onset and those never placed on cotrimoxazole or ART. CONCLUSION: Despite improving HIV testing rates and TB-HIV interventions, adverse outcomes in TB-HIV patients remain at about 26%. Characteristics predicting higher risk of adverse outcomes must be addressed if Viet Nam wishes to end the TB epidemic by 2030.
SETTING: The National Tuberculosis (TB) Programme in Viet Nam and Ho Chi Minh City (HCMC). OBJECTIVES: To determine 1) at national level between 2011 and 2013, the relationship between human immunodeficiency virus (HIV) testing, uptake of TB-HIV interventions and adverse treatment outcomes among TB-HIVpatients; and 2) in HCMC in 2013, patient characteristics associated with adverse outcomes. DESIGN: An ecological study reviewing aggregate nationwide data and a retrospective cohort review in HCMC. RESULTS: Nationwide, from 2011 to 2013, HIV testing increased in TB patients from 58% to 68% and antiretroviral therapy (ART) increased in TB-HIVpatients from 54% to 63%. Adverse treatment outcomes in TB-HIVpatients increased from 24% to 27%, largely due to transfer out (5-9% increase) and death. The Northern and Highland regions showed poor uptake of TB-HIV interventions. In HCMC, 303 (27%) of 1110 TB-HIVpatients had adverse outcomes, with higher risks observed in those with previously treated TB, those diagnosed as HIV-positive before TB onset and those never placed on cotrimoxazole or ART. CONCLUSION: Despite improving HIV testing rates and TB-HIV interventions, adverse outcomes in TB-HIVpatients remain at about 26%. Characteristics predicting higher risk of adverse outcomes must be addressed if Viet Nam wishes to end the TB epidemic by 2030.
Authors: O Ferroussier; R A Dlodlo; D Capo-Chichi; F Boillot; M Gninafon; A Trébucq; P I Fujiwara Journal: Int J Tuberc Lung Dis Date: 2013-11 Impact factor: 2.373
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Serena P Koenig; Cynthia Riviere; Paul Leger; Patrice Joseph; Patrice Severe; Kea Parker; Sean Collins; Erin Lee; Jean W Pape; Daniel W Fitzgerald Journal: Clin Infect Dis Date: 2009-03-15 Impact factor: 9.079
Authors: Amitabh B Suthar; Marco A Vitoria; Jason M Nagata; Xavier Anglaret; Dorothy Mbori-Ngacha; Omar Sued; Jonathan E Kaplan; Meg C Doherty Journal: Lancet HIV Date: 2015-03-03 Impact factor: 12.767
Authors: Kudakwashe C Takarinda; Anthony D Harries; Tsitsi Mutasa-Apollo; Charles Sandy; Owen Mugurungi Journal: BMC Public Health Date: 2012-11-15 Impact factor: 3.295